Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.81 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.81 |
| ▸ | PDE2A | O00408 | 1/20 | 0.81 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.81 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.81 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.81 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.78 |
| ▸ | NT5E | P21589 | 1/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.75 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.73 |
| ▸ | CA1 | P00915 | 1/20 | 0.72 |
| ▸ | CA2 | P00918 | 1/20 | 0.72 |
| ▸ | CA4 | P22748 | 1/20 | 0.72 |
| ▸ | CA9 | Q16790 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6837087 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL19953842 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL1663268 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL20128458 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL13863559 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL104094 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL1389446 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL397323 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL6886946 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A | |
| SCHEMBL4535914 | 1.00 | ADORA3 (0.81) | ADORA3ADORA2APDE2AADORA1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3013 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729063-A2 | TREATMENT OF CANCER USING COENZYME Q10 COMBINATION THERAPIES | BPGbio, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| US-12209285-B2 | Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10) | BPGBIO, INC. (US) | 2025-01-28 | — | — | US | claimed |
| EP-4444877-A2 | MODIFIED IMMUNE CELLS AND METHODS OF USING THE SAME | Beam Therapeutics Inc. (US) | 2024-10-16 | — | — | EP | claimed |
| CN-113943334-B | A, A 2A Process for preparing adenosine receptor agonists | 常州方圆制药有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-114249785-B | Preparation method of 2-adenosine N-pyrazole derivative regadenoson | 常州方圆制药有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117467726-A | Preparation method of purine nucleoside | 天津凯莱英生物科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| US-20240024243-A1 | Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same | LABORATORY SKIN CARE, INC. | 2024-01-25 | — | — | US | claimed |
| CN-117430647-A | Preparation method of regadenoson | 康普药业股份有限公司 | 2024-01-23 | — | — | CN | claimed |
| WO-2023108107-A2 | MODIFIED IMMUNE CELLS AND METHODS OF USING THE SAME | BEAM THERAPEUTICS INC. (US) | 2023-06-15 | — | — | WO | claimed |
| CN-110483602-B | Preparation method of regadenoson | 常州方圆制药有限公司 | 2022-05-17 | — | — | CN | claimed |
| WO-1998057651-A1 | COMPOSITIONS AND METHODS FOR PREVENTING RESTENOSIS FOLLOWING REVASCULARIZATION PROCEDURES | DISCOVERY THERAPEUTICS, INC. (US) | 1998-12-23 | — | — | WO | claimed |
| US-5679650-A | SIDE EFFECT REDUCTION | ADENOCOMP, LLC | 1997-10-21 | — | — | US | claimed |
| EP-0735888-A1 | PURINE COMPOSITIONS AND METHODS FOR ADMINISTRATION | FUKUNAGA, Atsuo F. (US) | 1996-10-09 | — | — | EP | claimed |
| US-5474929-A | Adenosine deaminase gene | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1995-12-12 | — | — | US | claimed |
| US-5424297-A | Adenosine dextran conjugates | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1995-06-13 | — | — | US | claimed |
| WO-1995014478-A1 | PURINE COMPOSITIONS AND METHODS FOR ADMINISTRATION | FUKUNAGA ATSUO F (US) | 1995-06-01 | — | — | WO | claimed |
| US-5284834-A | Coronary vasodilation | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-02-08 | — | — | US | claimed |
| US-5070877-A | Using adenosin receptor agonist | MEDCO RESEARCH, INC. (US) | 1991-12-10 | — | — | US | claimed |
| US-4948783-A | ORALLY ADMINISTERING ADENOSINE OR DERIVATIVE | KABUSHIKI KAISYA ADVANCE KAIHATSU KENKYUJO (JP) | 1990-08-14 | — | — | US | claimed |
| US-4311482-A | Method and apparatus for collecting blood samples | ABBOTT LABORATORIES (US) | 1982-01-19 | — | — | US | claimed |